Skip to main content
Log in

Comment prendre en charge les douleurs ostéo-articulaires d’un patient souffrant de maladies inflammatoires chroniques intestinales ?

How to treat osteoarticular pain in patient with inflammatory bowel disease?

  • Videodigest
  • Published:
Acta Endoscopica

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Références

  1. Puéchal X, Dernis E. Manifestations articulaires des affections intestinales. EMC — Appar Locomoteur 2006;1:1–7.

    Article  Google Scholar 

  2. Pedersen SJ, Weber U, Ostergaard M. The diagnostic utility of MRI in spondyloarthritis. Best Pract Res Clin Rheumatol 2012;26:751–66.

    Article  PubMed  Google Scholar 

  3. Leclerc-Jacob S, Lux G, Rat AC, Laurent V, Blum A, Chary-Valckenaere I, et al. The prevalence of inflammatory sacroiliitis assessed on magnetic resonance imaging of inflammatory bowel disease: a retrospective study performed on 186 patients. Aliment Pharmacol Ther 2014;39:957–62.

    Article  CAS  PubMed  Google Scholar 

  4. De Keyser F, Baeten D, Van den Bosch F, De Vos M, Cuvelier C, Mielants H, et al. Gut inflammation and spondyloarthropathies. Curr Rheumatol Rep 2002;4:525–32.

    Article  PubMed  Google Scholar 

  5. Kahn MF, Bouchon JP, Chamot AM, Palazzo E. Chronic enterocolopathies and SAPHO syndrome. 8 cases. Rev Rhum Mal Ostéo-Articul 1992;59:91–4.

    CAS  Google Scholar 

  6. Orchard T, Wordsworth B, Jewell D. Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history. Gut 1998;42:387–91.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  7. Bayless TM, Stevens MB. Letter: Granulomatous synovitis and Crohn’s disease. N Engl J Med 1976;294:903.

    CAS  PubMed  Google Scholar 

  8. Bandinelli F, Milla M, Genise S, Giovannini L, Bagnoli S, Candelieri A, et al. Ultrasound discloses entheseal involvement in inactive and low active inflammatory bowel disease without clinical signs and symptoms of spondyloarthropathy. Rheumatology 2011;50:1275–9.

    Article  PubMed  Google Scholar 

  9. Lioté F, Frazier A, Quemeneur AS, Ea HK. Le pied et la cheville des spondyloarthrites. Rev Rhum Monographies 2014;81:115–9.

    Article  Google Scholar 

  10. Amor B, Dougados M, Mijiyawa M. Criteria of the classification of spondylarthropathies. Rev Rhum Mal Ostéo-Articul 1990;57:85–9.

    CAS  Google Scholar 

  11. Sieper J, van der Heijde D, Landewé R, Brandt J, Burgos-Vagas R, Collantes-Estevez E, et al. New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS). Ann Rheum Dis 2009;68:784–8.

    Article  CAS  PubMed  Google Scholar 

  12. Sandborn WJ, Stenson WF, Brynskov J, Lorenz RG, Steidle GM, Robbins JL, et al. Safety of Celecoxib in Patients With Ulcerative Colitis in Remission: A Randomized, Placebo-Controlled, Pilot Study. Clin Gastroenterol Hepatol 2006;4:203–11.

    Article  CAS  PubMed  Google Scholar 

  13. El Miedany Y, Youssef S, Ahmed I, El Gaafary M. The Gastrointestinal Safety and Effect on Disease Activity of Etoricoxib, a Selective Cox-2 Inhibitor in Inflammatory Bowel Diseases. Am J Gastroenterol 2006;101:311–7.

    Article  PubMed  Google Scholar 

  14. Braun J, Baraliakos X, Listing J, Davis J, van der Heijde D, Haibel H, et al. Differences in the incidence of flares or new onset of inflammatory bowel diseases in patients with ankylosing spondylitis exposed to therapy with anti-tumor necrosis factor alpha agents. Arthritis Rheum 2007;57:639–47.

    Article  CAS  PubMed  Google Scholar 

  15. Maksymowych WP, Jhangri GS, Fitzgerald AA, LeClercq S, Chiu P, Yan A, et al. A six-month randomized, controlled, double-blind, dose-response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug–refractory ankylosing spondylitis. Arthritis Rheum 2002;46:766–73.

    Article  CAS  PubMed  Google Scholar 

  16. Dubost J-J, Tournadre A, Soubrier M, Ristori J-M. Arthrite septique à pyogène de l’adulte. EMC — Appar Locomoteur 2010;5:1–17.

    Article  Google Scholar 

  17. Dubost J-J, Tournadre A, Soubrier M, Ristori J-M. Spondylodiscite infectieuse non tuberculeuse. EMC — Appar Locomoteur 2006;1:1–11.

    Article  Google Scholar 

  18. Van Tjeerd-Pieter Cooper C, Samuels Brusse L, Leufkens H, Javaid MK, Arden NK. Inflammatory bowel disease and the risk of fracture. Gastroenterology 2003;125:1591–7.

    Article  Google Scholar 

  19. Melek J, Sakuraba A. Efficacy and Safety of Medical Therapy for Low Bone Mineral Density in Patients With Inflammatory Bowel Disease: A Meta-analysis and Systematic Review. Clin Gastroenterol Hepatol 2014;12:32–44.e5.

    Article  PubMed  Google Scholar 

  20. Hindorf U, Lindqvist M, Hildebrand H, Fagerberg U, Almer S. Adverse events leading to modification of therapy in a large cohort of patients with inflammatory bowel disease. Aliment Pharmacol Ther 2006;24:331–42.

    Article  CAS  PubMed  Google Scholar 

  21. Bannwarth B. Drug-induced musculoskeletal disorders. Drug Saf Int J Med Toxicol Drug Exp 2007;30:27–46.

    Article  CAS  Google Scholar 

  22. De Bandt M, Sibilia J, Le Loet X, Prouzeau S, Fautrel B, Marcelli C, et al. Systemic lupus erythematosus induced by antitumour necrosis factor alpha therapy: a French national survey. Arthritis Res Ther 2005;7:R545–R551.

    Article  PubMed Central  PubMed  Google Scholar 

  23. Costa MF, Said NR, Zimmermann B. Drug-Induced Lupus due to Anti-Tumor Necrosis Factor a Agents. Semin Arthritis Rheum 2008;37:381–7.

    Article  CAS  PubMed  Google Scholar 

  24. Moss AC, Brinks V, Carpenter JF. Review article: immunogenicity of anti-TNF biologics in IBD–the role of patient, product and prescriber factors. Aliment Pharmacol Ther 2013;38:1188–97.

    Article  CAS  PubMed  Google Scholar 

  25. Kneepkens EL, Wei JC, Nurmohamed MT, Yeo KJ, Chen CY, Horst-Bruinsma IE van der, et al. Immunogenicity, adalimumab levels and clinical response in ankylosing spondylitis patients during 24 weeks of follow-up. Ann Rheum Dis 2013; annrheumdis-2013-204185.

    Google Scholar 

  26. Hernigou P. Ostéonécroses non traumatiques des épiphyses de l’adulte. EMC — Appar Locomoteur 2006;1:1–15.

    Article  Google Scholar 

  27. Belmatoug N, et al. L’actualité rhumatologique 1992;p. 338.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. Frazier-Mironer.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Frazier-Mironer, A., Gonzalez, F., Lioté, F. et al. Comment prendre en charge les douleurs ostéo-articulaires d’un patient souffrant de maladies inflammatoires chroniques intestinales ?. Acta Endosc 44, 292–296 (2014). https://doi.org/10.1007/s10190-014-0415-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10190-014-0415-8

Navigation